Efficacy of intravitreal aflibercept in macular telangiectasia type 1 is linked to the ocular angiogenic profile

Kowalczuk, Laura; Matet, Alexandre; Dirani, Ali; Daruich, Alejandra; Ambresin, Aude; Mantel, Irmela; Spaide, Richard F; Turck, Natacha; Behar-Cohen, Francine

doi:10.1097/IAE.0000000000001424

Scientific article

English

Efficacy of intravitreal aflibercept in macular telangiectasia type 1 is linked to the ocular angiogenic profile

ContributorsKowalczuk, Laura; Matet, Alexandre; Dirani, Ali; Daruich, Alejandra; Ambresin, Aude; Mantel, Irmela; Spaide, Richard F; Turck, Natacha; Behar-Cohen, Francine

Published inRetina, vol. 37, no. 12, p. 2226-2237

Publication date2017

Abstract

To evaluate intravitreal aflibercept in macular telangiectasia Type 1 (MacTel 1) patients and measure their ocular angiogenic profile.

Affiliation entities

Faculté de médecine / Section de médecine fondamentale / Département de biologie structurale et bioinformatique

Research groups

Omics Panels of Tears Indicators for ocular and systemic Clinical Situations (957)

Citation (ISO format)

KOWALCZUK, Laura et al. Efficacy of intravitreal aflibercept in macular telangiectasia type 1 is linked to the ocular angiogenic profile. In: Retina, 2017, vol. 37, n° 12, p. 2226–2237. doi: 10.1097/IAE.0000000000001424

Article (Published version)

Identifiers

PID : unige:93647
DOI : 10.1097/IAE.0000000000001424
PMID : 28002269

Journal ISSN1539-2864

544views

359downloads

Creation01/09/2017 12:54:00 PM

First validation01/09/2017 12:54:00 PM

Update time03/15/2023 1:36:05 AM

Status update03/15/2023 1:36:04 AM

Last indexation10/31/2024 6:46:33 AM

Archive ouverte UNIGE

Efficacy of intravitreal aflibercept in macular telangiectasia type 1 is linked to the ocular angiogenic profile

To evaluate intravitreal aflibercept in macular telangiectasia Type 1 (MacTel 1) patients and measure their ocular angiogenic profile.

Technical informations